Paper
0
Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase
Authors
Tanya Paquet,Claire Manach
Diego Cabrera,Yassir Younis,Philipp Henrich,Tara Abraham,Lee M,Rajshekhar Basak,Sonja Ghidelli-Disse,María Lafuente-Monasterio,Marcus Bantscheff,Andrea Ruecker,Andrew Blagborough,Sara Zakutansky,Anne‐Marie Zeeman,Karen White,David Shackleford,Janne Mannila,Julia Morizzi,Christian Scheurer,Íñigo Angulo‐Barturen,María Martínez,Santiago Ferrer,Laura Sanz,Francisco‐Javier Gamo,Janette Reader,Mariëtte Botha,Koen Dechering,Robert Sauerwein,Anchalee Tungtaeng,Pattaraporn Vanachayangkul,Chek Lim,Jeremy Burrows,Michael Witty,Kennan Marsh,Christophe Bodenreider,Rosemary Rochford,Suresh Solapure,Marı́a Jiménez-Dı́az,Sergio Wittlin,Susan Charman,Cristina Donini,Brice Campo,Lyn‐Marié Birkholtz,Kirsten Hanson,Gerard Drewes,Clemens Kocken,Michael Delves,Didier Leroy,David Fidock,David Waterson,Leslie Street,Kelly Chibale
+51 authors
,Alan ThomasPublished
Apr 26, 2017
Show more
Save
Tip0
TipSave
Abstract
MMV390048, a member of a new class of inhibitors of the Plasmodium phosphatidylinositol 4-kinase, shows potential for both treatment and prophylaxis.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.